Mohamed Aghar Elrayess

Director of Basic Research, Vice President for Medical and Health Sciences Office (QU)

Dr Mohamed Elrayess is the director of basic research at Qatar University’s Health Cluster. He has a PhD in cardiovascular genetics from University College London, United Kingdom, in 2003. He worked as a postdoctoral fellow at the Cardiovascular Medicine unit at University College London (2003-2004) and as a scientist at Eisai (2004-2012), a top international pharmaceutical company, where he developed skills in drug discovery and development, mainly focusing on stem cell therapy. He then spent the following 7 years (2012-2019) working as a senior scientist at Anti-Doping Lab Qatar, an international testing laboratory for doping abuse in elite athletes, using various OMICS approaches for the identification of novel biomarkers of insulin resistance and diabetes and investigating genetics and metabolomics of elite athletes.  Dr. Elrayess joined Qatar University in 2019 as a Research Associate Professor at the Biomedical Research Center, spearheading the OMICS research group. His work centers on exploring novel biomarkers and therapeutic targets in insulin resistance and diabetes through Pharmacometabolomics and Pharmacogenomics approaches. He has over 80 publications, supervised 3 PhD students and a number of MSc students and raised more than 4 million USD research funding.